{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:45:49Z","timestamp":1793411149641,"version":"4.5.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41587-025-02570-7","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:02:27Z","timestamp":1739854947000},"page":"90-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Sustained in situ protein production and release in the mammalian gut by an engineered bacteriophage"],"prefix":"10.1038","volume":"44","author":[{"given":"Zachary R.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-090X","authenticated-orcid":false,"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hollyn C.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6073-2172","authenticated-orcid":false,"given":"Priscila B. S.","family":"Serpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Southard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8870-5299","authenticated-orcid":false,"given":"Liwu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8219-1124","authenticated-orcid":false,"given":"Bryan B.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"2570_CR1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3389\/fphar.2020.00524","volume":"11","author":"S Hua","year":"2020","unstructured":"Hua, S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract\u2014influence of physiological, pathophysiological and pharmaceutical factors. Front. Pharmacol. 11, 524 (2020).","journal-title":"Front. Pharmacol."},{"key":"2570_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/pharmaceutics11040193","volume":"11","author":"J Tripathi","year":"2019","unstructured":"Tripathi, J., Thapa, P., Maharjan, R. & Jeong, S. H. Currentstate and future perspectives on gastroretentive drug delivery systems. Pharmaceutics 11, 193 (2019).","journal-title":"Pharmaceutics"},{"key":"2570_CR3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/pharmaceutics13010018","volume":"13","author":"R New","year":"2020","unstructured":"New, R. Oral delivery of biologics via the intestine. Pharmaceutics 13, 18 (2020).","journal-title":"Pharmaceutics"},{"key":"2570_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/pharmaceutics11080411","volume":"11","author":"D Dahlgren","year":"2019","unstructured":"Dahlgren, D. & Lennernas, H. Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches. Pharmaceutics 11, 411 (2019).","journal-title":"Pharmaceutics"},{"key":"2570_CR5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4065\/mcp.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown, M. T. & Bussell, J. K. Medication adherence: WHO cares? Mayo Clin. Proc. 86, 304\u2013314 (2011).","journal-title":"Mayo Clin. Proc."},{"key":"2570_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd1111","volume":"2","author":"CR Merril","year":"2003","unstructured":"Merril, C. R., Scholl, D. & Adhya, S. L. The prospect for bacteriophage therapy in Western medicine. Nat. Rev. Drug Discov. 2, 489\u2013497 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2570_CR7","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1073\/pnas.1305923110","volume":"110","author":"JJ Barr","year":"2013","unstructured":"Barr, J. J. et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc. Natl Acad. Sci. USA 110, 10771\u201310776 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2570_CR8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/v11010010","volume":"11","author":"JD Van Belleghem","year":"2018","unstructured":"Van Belleghem, J. D., Dabrowska, K., Vaneechoutte, M., Barr, J. J. & Bollyky, P. L. Interactions between bacteriophage, bacteria, and the mammalian immune system. Viruses 11, 10 (2018).","journal-title":"Viruses"},{"key":"2570_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chom.2019.09.009","volume":"26","author":"AN Shkoporov","year":"2019","unstructured":"Shkoporov, A. N. et al. The human gut virome is highly diverse, stable, and individual specific. Cell Host Microbe 26, 527\u2013541 e525 (2019).","journal-title":"Cell Host Microbe"},{"key":"2570_CR10","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1073\/pnas.1300833110","volume":"110","author":"S Minot","year":"2013","unstructured":"Minot, S. et al. Rapid evolution of the human gut virome. Proc. Natl Acad. Sci. USA 110, 12450\u201312455 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2570_CR11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07225-7","volume":"9","author":"AN Shkoporov","year":"2018","unstructured":"Shkoporov, A. N. et al. PhiCrAss001 represents the most abundant bacteriophage family in the human gut and infects Bacteroides intestinalis. Nat. Commun. 9, 4781 (2018).","journal-title":"Nat. Commun."},{"key":"2570_CR12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.virol.2009.07.020","volume":"393","author":"M Weiss","year":"2009","unstructured":"Weiss, M. et al. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Virology 393, 16\u201323 (2009).","journal-title":"Virology"},{"key":"2570_CR13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.chom.2019.05.001","volume":"25","author":"BB Hsu","year":"2019","unstructured":"Hsu, B. B. et al. Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model. Cell Host Microbe 25, 803\u2013814 (2019).","journal-title":"Cell Host Microbe"},{"key":"2570_CR14","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1111\/j.1462-2920.2011.02644.x","volume":"14","author":"D Maura","year":"2012","unstructured":"Maura, D. et al. Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice. Environ. Microbiol. 14, 1844\u20131854 (2012).","journal-title":"Environ. Microbiol."},{"key":"2570_CR15","doi-asserted-by":"crossref","first-page":"e0013621","DOI":"10.1128\/CMR.00136-21","volume":"34","author":"F Javaudin","year":"2021","unstructured":"Javaudin, F., Latour, C., Debarbieux, L. & Lamy-Besnier, Q. Intestinal bacteriophage therapy: looking for optimal efficacy. Clin. Microbiol. Rev. 34, e0013621 (2021).","journal-title":"Clin. Microbiol. Rev."},{"key":"2570_CR16","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.98","volume":"4","author":"N Tennoune","year":"2014","unstructured":"Tennoune, N. et al. Bacterial ClpB heat-shock protein, an antigen-mimetic of the anorexigenic peptide \u03b1-MSH, at the origin of eating disorders. Transl. Psychiatry 4, e458 (2014).","journal-title":"Transl. Psychiatry"},{"key":"2570_CR17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41366-019-0515-9","volume":"44","author":"R Legrand","year":"2020","unstructured":"Legrand, R. et al. Commensal Hafnia alvei strain reduces food intake and fat mass in obese mice\u2014a new potential probiotic for appetite and body weight management. Int. J. Obes. 44, 1041\u20131051 (2020).","journal-title":"Int. J. Obes."},{"key":"2570_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/MMBR.67.1.86-156.2003","volume":"67","author":"ES Miller","year":"2003","unstructured":"Miller, E. S. et al. Bacteriophage T4 genome. Microbiol. Mol. Biol. Rev. 67, 86\u2013156 (2003).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"2570_CR19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/viro.2002.1409","volume":"299","author":"K Luke","year":"2002","unstructured":"Luke, K. et al. Microarray analysis of gene expression during bacteriophage T4 infection. Virology 299, 182\u2013191 (2002).","journal-title":"Virology"},{"key":"2570_CR20","unstructured":"Grigonyte, A. Engineering Bacteriophages to Enhance their Potential Use in Therapy (University of Warwick, 2018)."},{"key":"2570_CR21","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1039\/D0AN01413C","volume":"145","author":"MM Duong","year":"2020","unstructured":"Duong, M. M., Carmody, C. M. & Nugen, S. R. Phage-based biosensors: in vivo analysis of native T4 phage promoters to enhance reporter enzyme expression. Analyst 145, 6291\u20136297 (2020).","journal-title":"Analyst"},{"key":"2570_CR22","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1128\/JB.186.21.7262-7272.2004","volume":"186","author":"B Tiemann","year":"2004","unstructured":"Tiemann, B. et al. ModA and ModB, two ADP-ribosyltransferases encoded by bacteriophage T4: catalytic properties and mutation analysis. J. Bacteriol. 186, 7262\u20137272 (2004).","journal-title":"J. Bacteriol."},{"key":"2570_CR23","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1073\/pnas.0400444101","volume":"101","author":"A Fokine","year":"2004","unstructured":"Fokine, A. et al. Molecular architecture of the prolate head of bacteriophage T4. Proc. Natl Acad. Sci. USA 101, 6003\u20136008 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2570_CR24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2217\/fmb.14.91","volume":"9","author":"ML Yap","year":"2014","unstructured":"Yap, M. L. & Rossmann, M. G. Structure and function of bacteriophage T4. Future Microbiol. 9, 1319\u20131327 (2014).","journal-title":"Future Microbiol."},{"key":"2570_CR25","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1128\/IAI.73.12.8039-8049.2005","volume":"73","author":"MP Leatham","year":"2005","unstructured":"Leatham, M. P. et al. Mouse intestine selects nonmotile flhDC mutants of Escherichia coli MG1655 with increased colonizing ability and better utilization of carbon sources. Infect. Immun. 73, 8039\u20138049 (2005).","journal-title":"Infect. Immun."},{"key":"2570_CR26","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1128\/iai.64.9.3497-3503.1996","volume":"64","author":"NJ Sweeney","year":"1996","unstructured":"Sweeney, N. J. et al. The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine. Infect. Immun. 64, 3497\u20133503 (1996).","journal-title":"Infect. Immun."},{"key":"2570_CR27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/JIR.S234710","volume":"13","author":"R Curciarello","year":"2020","unstructured":"Curciarello, R. et al. Human neutrophil elastase proteolytic activity in ulcerative colitis favors the loss of function of therapeutic monoclonal antibodies. J. Inflamm. Res. 13, 233\u2013243 (2020).","journal-title":"J. Inflamm. Res."},{"key":"2570_CR28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41385-019-0235-4","volume":"13","author":"R Barry","year":"2020","unstructured":"Barry, R. et al. Faecal neutrophil elastase-antiprotease balance reflects colitis severity. Mucosal Immunol. 13, 322\u2013333 (2020).","journal-title":"Mucosal Immunol."},{"key":"2570_CR29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41423-021-00832-3","volume":"19","author":"A Herrero-Cervera","year":"2022","unstructured":"Herrero-Cervera, A., Soehnlein, O. & Kenne, E. Neutrophils in chronic inflammatory diseases. Cell Mol. Immunol. 19, 177\u2013191 (2022).","journal-title":"Cell Mol. Immunol."},{"key":"2570_CR30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00535-005-1768-8","volume":"41","author":"Y Morohoshi","year":"2006","unstructured":"Morohoshi, Y. et al. Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. J. Gastroenterol. 41, 318\u2013324 (2006).","journal-title":"J. Gastroenterol."},{"key":"2570_CR31","doi-asserted-by":"crossref","first-page":"562587","DOI":"10.3389\/fimmu.2020.562587","volume":"11","author":"NGF Leborgne","year":"2020","unstructured":"Leborgne, N. G. F., Taddeo, A., Freigang, S. & Benarafa, C. Serpinb1a is dispensable for the development and cytokine response of invariant natural killer T cell subsets. Front. Immunol. 11, 562587 (2020).","journal-title":"Front. Immunol."},{"key":"2570_CR32","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00011-023-01779-z","volume":"72","author":"R Lin","year":"2023","unstructured":"Lin, R. et al. Resolving neutrophils due to TRAM deletion renders protection against experimental sepsis. Inflamm. Res. 72, 1733\u20131744 (2023).","journal-title":"Inflamm. Res."},{"key":"2570_CR33","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1038\/s44321-024-00100-7","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Immune-enhancing neutrophils reprogrammed by subclinical low-dose endotoxin in cancer treatment. EMBO Mol. Med. 16, 1886\u20131900 (2024).","journal-title":"EMBO Mol. Med."},{"key":"2570_CR34","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/science.1168988","volume":"323","author":"GY Chen","year":"2009","unstructured":"Chen, G. Y., Tang, J., Zheng, P. & Liu, Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323, 1722\u20131725 (2009).","journal-title":"Science"},{"key":"2570_CR35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/mi.2016.14","volume":"9","author":"RK Boyapati","year":"2016","unstructured":"Boyapati, R. K., Rossi, A. G., Satsangi, J. & Ho, G. T. Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications. Mucosal Immunol. 9, 567\u2013582 (2016).","journal-title":"Mucosal Immunol."},{"key":"2570_CR36","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/CIRCRESAHA.124.325023","volume":"135","author":"S Geng","year":"2024","unstructured":"Geng, S. et al. Monocytes reprogrammed by 4-PBA potently contribute to the resolution of inflammation and atherosclerosis. Circ. Res. 135, 856\u2013872 (2024).","journal-title":"Circ. Res."},{"key":"2570_CR37","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.cmet.2022.07.005","volume":"34","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder. Cell Metab. 34, 1088\u20131103 (2022).","journal-title":"Cell Metab."},{"key":"2570_CR38","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ibd.21134","volume":"16","author":"MA Ahmed","year":"2010","unstructured":"Ahmed, M. A. et al. CD24 is upregulated in inflammatory bowel disease and stimulates cell motility and colony formation. Inflamm. Bowel Dis. 16, 795\u2013803 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"2570_CR39","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3390\/nu13061902","volume":"13","author":"P Dechelotte","year":"2021","unstructured":"Dechelotte, P. et al. The probiotic strain H. alvei HA4597((R)) improves weight loss in overweight subjects under moderate hypocaloric diet: a proof-of-concept, multicenter randomized, double-blind placebo-controlled study. Nutrients 13, 1902 (2021).","journal-title":"Nutrients"},{"key":"2570_CR40","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.3390\/nu13072223","volume":"13","author":"M Dominique","year":"2021","unstructured":"Dominique, M. et al. Effects of bacterial CLPB protein fragments on food intake and PYY secretion. Nutrients 13, 2223 (2021).","journal-title":"Nutrients"},{"key":"2570_CR41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.cmet.2014.10.004","volume":"20","author":"BL Panaro","year":"2014","unstructured":"Panaro, B. L. et al. The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo. Cell Metab. 20, 1018\u20131029 (2014).","journal-title":"Cell Metab."},{"key":"2570_CR42","doi-asserted-by":"crossref","first-page":"101206","DOI":"10.1016\/j.molmet.2021.101206","volume":"48","author":"GSH Yeo","year":"2021","unstructured":"Yeo, G. S. H. et al. The melanocortin pathway and energy homeostasis: from discovery to obesity therapy. Mol. Metab. 48, 101206 (2021).","journal-title":"Mol. Metab."},{"key":"2570_CR43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.chom.2020.06.002","volume":"28","author":"M Lourenco","year":"2020","unstructured":"Lourenco, M. et al. The spatial heterogeneity of the gut limits predation and fosters coexistence of bacteria and bacteriophages. Cell Host Microbe 28, 390\u2013401 (2020).","journal-title":"Cell Host Microbe"},{"key":"2570_CR44","doi-asserted-by":"crossref","first-page":"e00926","DOI":"10.1128\/IAI.00926-19","volume":"88","author":"MR Mangalea","year":"2020","unstructured":"Mangalea, M. R. & Duerkop, B. A. Fitness trade-offs resulting from bacteriophage resistance potentiate synergistic antibacterial strategies. Infect. Immun. 88, e00926 (2020).","journal-title":"Infect. Immun."},{"key":"2570_CR45","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821\u20131830 (2003).","journal-title":"J. Clin. Invest."},{"key":"2570_CR46","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860\u2013867 (2006).","journal-title":"Nature"},{"key":"2570_CR47","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen, K. E. & Hotamisligil, G. S. Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111\u20131119 (2005).","journal-title":"J. Clin. Invest."},{"key":"2570_CR48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2567.2011.03522.x","volume":"135","author":"C Tang","year":"2012","unstructured":"Tang, C., Chen, S., Qian, H. & Huang, W. Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology 135, 112\u2013124 (2012).","journal-title":"Immunology"},{"key":"2570_CR49","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/imm.12946","volume":"154","author":"LMS Martins","year":"2018","unstructured":"Martins, L. M. S. et al. Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model. Immunology 154, 624\u2013636 (2018).","journal-title":"Immunology"},{"key":"2570_CR50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ijo.2008.216","volume":"33","author":"M Sumarac-Dumanovic","year":"2009","unstructured":"Sumarac-Dumanovic, M. et al. Increased activity of interleukin-23\/interleukin-17 proinflammatory axis in obese women. Int. J. Obes. 33, 151\u2013156 (2009).","journal-title":"Int. J. Obes."},{"key":"2570_CR51","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","volume":"116","author":"Y Iwakura","year":"2006","unstructured":"Iwakura, Y. & Ishigame, H. The IL-23\/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218\u20131222 (2006).","journal-title":"J. Clin. Invest."},{"key":"2570_CR52","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","volume":"116","author":"H Kanda","year":"2006","unstructured":"Kanda, H. et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494\u20131505 (2006).","journal-title":"J. Clin. Invest."},{"key":"2570_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2012.06.018","volume":"60","author":"J Panee","year":"2012","unstructured":"Panee, J. Monocyte chemoattractant protein 1 (MCP-1) in obesity and diabetes. Cytokine 60, 1\u201312 (2012).","journal-title":"Cytokine"},{"key":"2570_CR54","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.1133870100","volume":"100","author":"P Sartipy","year":"2003","unstructured":"Sartipy, P. & Loskutoff, D. J. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl Acad. Sci. USA 100, 7265\u20137270 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2570_CR55","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4161\/gmic.19625","volume":"3","author":"PD Cani","year":"2012","unstructured":"Cani, P. D., Osto, M., Geurts, L. & Everard, A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3, 279\u2013288 (2012).","journal-title":"Gut Microbes"},{"key":"2570_CR56","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1006\/jmbi.1996.0281","volume":"258","author":"F Tetart","year":"1996","unstructured":"Tetart, F., Repoila, F., Monod, C. & Krisch, H. M. Bacteriophage T4 host range is expanded by duplications of a small domain of the tail fiber adhesin. J. Mol. Biol. 258, 726\u2013731 (1996).","journal-title":"J. Mol. Biol."},{"key":"2570_CR57","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.0812600106","volume":"106","author":"H Zhang","year":"2009","unstructured":"Zhang, H. et al. Human gut microbiota in obesity and after gastric bypass. Proc. Natl Acad. Sci. USA 106, 2365\u20132370 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2570_CR58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12866-017-1052-0","volume":"17","author":"Y Yun","year":"2017","unstructured":"Yun, Y. et al. Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort. BMC Microbiol. 17, 151 (2017).","journal-title":"BMC Microbiol."},{"key":"2570_CR59","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41564-019-0494-6","volume":"4","author":"RA Edwards","year":"2019","unstructured":"Edwards, R. A. et al. Global phylogeography and ancient evolution of the widespread human gut virus crAssphage. Nat. Microbiol. 4, 1727\u20131736 (2019).","journal-title":"Nat. Microbiol."},{"key":"2570_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15508-1","volume":"11","author":"MR Charbonneau","year":"2020","unstructured":"Charbonneau, M. R., Isabella, V. M., Li, N. & Kurtz, C. B. Developing a new class of engineered live bacterial therapeutics to treat human diseases. Nat. Commun. 11, 1738 (2020).","journal-title":"Nat. Commun."},{"key":"2570_CR61","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nbt.4222","volume":"36","author":"VM Isabella","year":"2018","unstructured":"Isabella, V. M. et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat. Biotechnol. 36, 857\u2013864 (2018).","journal-title":"Nat. Biotechnol."},{"key":"2570_CR62","doi-asserted-by":"crossref","first-page":"eaau7975","DOI":"10.1126\/scitranslmed.aau7975","volume":"11","author":"CB Kurtz","year":"2019","unstructured":"Kurtz, C. B. et al. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci. Transl. Med. 11, eaau7975 (2019).","journal-title":"Sci. Transl. Med."},{"key":"2570_CR63","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1128\/AAC.00602-12","volume":"56","author":"D Maura","year":"2012","unstructured":"Maura, D., Galtier, M., Le Bouguenec, C. & Debarbieux, L. Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine. Antimicrob. Agents Chemother. 56, 6235\u20136242 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2570_CR64","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/1743-422X-7-288","volume":"7","author":"EP Geiduschek","year":"2010","unstructured":"Geiduschek, E. P. & Kassavetis, G. A. Transcription of the T4 late genes. Virol J. 7, 288 (2010).","journal-title":"Virol J."},{"key":"2570_CR65","doi-asserted-by":"crossref","unstructured":"Stirling, F. et al. Rational design of evolutionarily stable microbial kill switches. Mol. Cell 68, 686\u2013697 (2017).","DOI":"10.1016\/j.molcel.2017.10.033"},{"key":"2570_CR66","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28163-5","volume":"13","author":"AG Rottinghaus","year":"2022","unstructured":"Rottinghaus, A. G., Ferreiro, A., Fishbein, S. R. S., Dantas, G. & Moon, T. S. Genetically stable CRISPR-based kill switches for engineered microbes. Nat. Commun. 13, 672 (2022).","journal-title":"Nat. Commun."},{"key":"2570_CR67","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/mbo3.266","volume":"4","author":"M Smati","year":"2015","unstructured":"Smati, M. et al. Quantitative analysis of commensal Escherichia coli populations reveals host-specific enterotypes at the intra-species level. Microbiologyopen 4, 604\u2013615 (2015).","journal-title":"Microbiologyopen"},{"key":"2570_CR68","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nrmicro2298","volume":"8","author":"O Tenaillon","year":"2010","unstructured":"Tenaillon, O., Skurnik, D., Picard, B. & Denamur, E. The population genetics of commensal Escherichia coli. Nat. Rev. Microbiol. 8, 207\u2013217 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"2570_CR69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","volume":"186","author":"SA Strathdee","year":"2023","unstructured":"Strathdee, S. A., Hatfull, G. F., Mutalik, V. K. & Schooley, R. T. Phage therapy: from biological mechanisms to future directions. Cell 186, 17\u201331 (2023).","journal-title":"Cell"},{"key":"2570_CR70","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chom.2019.01.008","volume":"25","author":"L Gogokhia","year":"2019","unstructured":"Gogokhia, L. et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis. Cell Host Microbe 25, 285\u2013299 (2019).","journal-title":"Cell Host Microbe"},{"key":"2570_CR71","first-page":"e01874","volume":"8","author":"S Nguyen","year":"2017","unstructured":"Nguyen, S. et al. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mBio 8, e01874 (2017).","journal-title":"mBio"},{"key":"2570_CR72","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.chom.2019.10.009","volume":"26","author":"AG Clooney","year":"2019","unstructured":"Clooney, A. G. et al. Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease. Cell Host Microbe 26, 764\u2013778 (2019).","journal-title":"Cell Host Microbe"},{"key":"2570_CR73","doi-asserted-by":"crossref","first-page":"e3647","DOI":"10.1371\/journal.pone.0003647","volume":"3","author":"C Engler","year":"2008","unstructured":"Engler, C., Kandzia, R. & Marillonnet, S. A one pot, one step, precision cloning method with high throughput capability. PLoS ONE 3, e3647 (2008).","journal-title":"PLoS ONE"},{"key":"2570_CR74","volume":"11","author":"Q Yan","year":"2017","unstructured":"Yan, Q. & Fong, S. S. Study of in vitro transcriptional binding effects and noise using constitutive promoters combined with UP element sequences in Escherichia coli. J. Biol. Eng. 11, 33 (2017).","journal-title":"J. Biol. Eng."},{"key":"2570_CR75","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152, 1173\u20131183 (2013).","journal-title":"Cell"},{"key":"2570_CR76","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1073\/pnas.53.1.24","volume":"53","author":"S Silver","year":"1965","unstructured":"Silver, S. Acriflavine resistance: a bacteriophage mutation affecting the uptake of dye by the infected bacterial cells. Proc. Natl Acad. Sci. USA 53, 24\u201330 (1965).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2570_CR77","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/genetics\/148.4.1655","volume":"148","author":"FJ Wang","year":"1998","unstructured":"Wang, F. J. & Ripley, L. S. The spectrum of acridine resistant mutants of bacteriophage T4 reveals cryptic effects of the tsL141 DNA polymerase allele on spontaneous mutagenesis. Genetics 148, 1655\u20131665 (1998).","journal-title":"Genetics"},{"key":"2570_CR78","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1021\/acs.biochem.9b00724","volume":"58","author":"S Park","year":"2019","unstructured":"Park, S., Reyer, M. A., McLean, E. L., Liu, W. & Fei, J. An improved method for bacterial immunofluorescence staining to eliminate antibody exclusion from the fixed nucleoid. Biochemistry 58, 4457\u20134465 (2019).","journal-title":"Biochemistry"},{"key":"2570_CR79","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1371\/journal.pbio.0040193","volume":"4","author":"M De Paepe","year":"2006","unstructured":"De Paepe, M. & Taddei, F. Viruses\u2019 life history: towards a mechanistic basis of a trade-off between survival and reproduction among phages. PLoS Biol. 4, e193 (2006).","journal-title":"PLoS Biol."},{"key":"2570_CR80","doi-asserted-by":"crossref","unstructured":"Weichhart, T. mTor: Methods and Protocols (Humana Press, 2012).","DOI":"10.1007\/978-1-61779-430-8"},{"key":"2570_CR81","unstructured":"Charles River Research Model. C57BL\/6 Mouse Clinical Pathology Data, C57BL\/6 mouse hematology: North American colonies. (2012)."},{"key":"2570_CR82","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2570_CR83","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"2570_CR84","doi-asserted-by":"crossref","first-page":"e0188257","DOI":"10.1371\/journal.pone.0188257","volume":"12","author":"Y Hasegawa","year":"2017","unstructured":"Hasegawa, Y., Mark Welch, J. L., Rossetti, B. J. & Borisy, G. G. Preservation of three-dimensional spatial structure in the gut microbiome. PLoS ONE 12, e0188257 (2017).","journal-title":"PLoS ONE"},{"key":"2570_CR85","unstructured":"Baker, Z. 16S Illumina sequencing reads. Mendeley Data data.mendeley.com\/datasets\/pt9m6b9s4z\/1 (2024)."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02570-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02570-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02570-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:02:02Z","timestamp":1768518122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02570-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2570"],"URL":"https:\/\/doi.org\/10.1038\/s41587-025-02570-7","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Z.B., L.L. and B.B.H. are inventors on a pending patent application related to the phage-based heterologous gene expression system described in this paper. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}